MW 506.3 Da, Purity >98%. Selective pan-Raf kinase inhibitor. Orally active. Achieve your results faster with highly validated, pure and trusted compounds.
MW 506.3 Da, Purity >98%. Selective pan-Raf kinase inhibitor. Orally active. Achieve your results faster with highly validated, pure and trusted compounds.
Selective pan-Raf kinase inhibitor. Orally active.
This product is manufactured by BioVision, an Abcam company and was previously called B1706 MLN2480. B1706-25 is the same size as the 25 mg size of ab235508.
Protect from air and light.
Soluble in DMSO.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com